세계의 불면증 약리학적 치료 시장 : 약제, 치료법, 유통 채널별 예측(2025-2030년)

The Insomnia Pharmacological Treatment Market was valued at USD 6.58 billion in 2023, expected to reach USD 7.01 billion in 2024, and is projected to grow at a CAGR of 7.07%, to USD 10.62 billion by 2030.

The scope of insomnia pharmacological treatment primarily includes prescription and over-the-counter medications used to manage sleeplessness, characterized by difficulty in falling asleep or maintaining sleep. These treatments are necessary due to the high prevalence of insomnia, which can adversely affect mental and physical health and diminish the quality of life. Their application spans various end-users, including hospitals, clinics, and retail pharmacies, often used by adults and increasingly by the elderly population. Key growth factors influencing the market include rising stress levels, a growing geriatric populace, increasing awareness about mental health, and advances in medication with fewer side effects. Moreover, the advent of digital health tools that assist in patient management presents a potential opportunity for enhancing treatment efficacy and customization. Opportunities abound in developing medications with unique mechanisms of action and fewer dependencies, as well as leveraging AI for personalized medicine approaches. However, the market growth faces limitations from the side effects of long-term medication use, regulatory challenges, and alternative non-pharmacological treatments like cognitive behavioral therapy. Furthermore, the potential for abuse or dependency on some insomnia medications is a pressing concern. Innovation in this area revolves around developing safer, non-habit-forming options and leveraging biotechnology to create drugs that target specific neurotransmitters better. Research into understanding the complexities of insomnia-associated disorders offers fertile ground for breakthroughs. The market is characterized by a dynamic and competitive landscape with both established pharmaceutical giants and emerging biotech startups leading research in novel therapeutics. Cooperation with digital health platforms also signals a significant trend towards holistic insomnia management, highlighting the synergy between medical treatment and technological advancement. Companies aiming for market leadership should prioritize R&D investments focused on these emerging scientific and technological trends while navigating through the regulatory and clinical trial landscape effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insomnia Pharmacological Treatment Market

The Insomnia Pharmacological Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of different types of sleep disorders including insomnia and parasomnias
  • Surge in work related stress level and physical disorders
  • Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
• Market Restraints
  • Side effects associated with certain OTC and prescription medication
• Market Opportunities
  • Development of novel products through efficient R&D activities
  • Advancement in non-pharmacological therapy to improve sleep quality
• Market Challenges
  • Individual level stigma about insomnia in some patients

Porter's Five Forces: A Strategic Tool for Navigating the Insomnia Pharmacological Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insomnia Pharmacological Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insomnia Pharmacological Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insomnia Pharmacological Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insomnia Pharmacological Treatment Market

A detailed market share analysis in the Insomnia Pharmacological Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insomnia Pharmacological Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insomnia Pharmacological Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insomnia Pharmacological Treatment Market

A strategic analysis of the Insomnia Pharmacological Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Pharmacological Treatment Market, highlighting leading vendors and their innovative profiles. These include Aa Pharma Inc., Amneal Pharmaceuticals LLC, BlaQmax by Akay Natural Ingredients Private Limited, Dr. Reddy's Laboratories, Eisai Co., Ltd., Fresenius Kabi AG, Gemini Pharmaceuticals, Idorsia Pharmaceuticals Ltd., Ingenus Pharmaceuticals, Makers Nutrition, LLC, Merck & Co., Inc., Micro Labs Limited, Paratek Pharmaceuticals, Inc., Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sivem Pharmaceuticals ULC, Sleepme Inc., SMP Nutra, Sumitomo Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Tru Body Wellness, Vanda Pharmaceuticals, Vera Herbals LLC, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Insomnia Pharmacological Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug, market is studied across OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements, and Prescription Drugs.
• Based on Treatment, market is studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids is further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids is further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists. The Non-benzodiazepines is further studied across Eszopiclone, Zaleplon, and Zolpidem.
• Based on Distribution Channel, market is studied across Drug Stores, E-Commerce, Hospital Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of different types of sleep disorders including insomnia and parasomnias
    • 5.1.1.2. Surge in work related stress level and physical disorders
    • 5.1.1.3. Increasing visits to doctor regarding to insomnia owing to rising awareness among patients
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with certain OTC and prescription medication
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of novel products through efficient R&D activities
    • 5.1.3.2. Advancement in non-pharmacological therapy to improve sleep quality
  • 5.1.4. Challenges
    • 5.1.4.1. Individual level stigma about insomnia in some patients
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Insomnia Pharmacological Treatment Market, by Drug

• 6.1. Introduction
• 6.2. OTC Drugs
• 6.3. OTC Sleep Aids
• 6.4. OTC Sleep Supplements
• 6.5. Prescription Drugs

7. Insomnia Pharmacological Treatment Market, by Treatment

• 7.1. Introduction
• 7.2. Over-the-Counter Sleep Aids
  • 7.2.1. Antihistamines
  • 7.2.2. Melatonin
  • 7.2.3. Valerian Roots
• 7.3. Prescription Sleep Aids
  • 7.3.1. Benzodiazepines
  • 7.3.2. Melatonin Receptor Antagonists
  • 7.3.3. Non-benzodiazepines
    • 7.3.3.1. Eszopiclone
    • 7.3.3.2. Zaleplon
    • 7.3.3.3. Zolpidem
  • 7.3.4. Orexin Antagonists

8. Insomnia Pharmacological Treatment Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. E-Commerce
• 8.4. Hospital Pharmacies
• 8.5. Retail Pharmacies

9. Americas Insomnia Pharmacological Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Insomnia Pharmacological Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Insomnia Pharmacological Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aa Pharma Inc.
• 2. Amneal Pharmaceuticals LLC
• 3. BlaQmax by Akay Natural Ingredients Private Limited
• 4. Dr. Reddy's Laboratories
• 5. Eisai Co., Ltd.
• 6. Fresenius Kabi AG
• 7. Gemini Pharmaceuticals
• 8. Idorsia Pharmaceuticals Ltd.
• 9. Ingenus Pharmaceuticals
• 10. Makers Nutrition, LLC
• 11. Merck & Co., Inc.
• 12. Micro Labs Limited
• 13. Paratek Pharmaceuticals, Inc.
• 14. Pfizer Inc.
• 15. Purdue Pharma L.P.
• 16. Sanofi S.A.
• 17. Sivem Pharmaceuticals ULC
• 18. Sleepme Inc.
• 19. SMP Nutra
• 20. Sumitomo Pharma Co., Ltd.
• 21. Takeda Pharmaceuticals Company Ltd.
• 22. TriVue Pharmaceuticals, Inc.
• 23. Tru Body Wellness
• 24. Vanda Pharmaceuticals
• 25. Vera Herbals LLC
• 26. Viatris Inc.